Advertisement

Topics

Parkinson’s Disease Gene Therapy Clinical Trial Launched in UK

09:45 EDT 25 Oct 2018 | Labiotech.eu

A gene therapy for Parkinson’s disease developed by Swiss biotech Axovant has been used on the first patient in a Phase I/II trial at University College London. Parkinson’s disease is a neurodegenerative disease, caused by a lack of the neurochemical ...

The post Parkinson’s Disease Gene Therapy Clinical Trial Launched in UK appeared first on Labiotech.eu.

Original Article: Parkinson’s Disease Gene Therapy Clinical Trial Launched in UK

NEXT ARTICLE

More From BioPortfolio on "Parkinson’s Disease Gene Therapy Clinical Trial Launched in UK"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Parkinson's Disease
Parkinson's is a progressive neurological condition, affecting one person in every 500, 95% of which are over 40. It is caused by degeneration of more than 70% of the substantia nigra, which depletes the dopamine (the neurotransmitter involved in pro...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...